Effect of Interventions for Premature Ejaculation in the Treatment of Chronic Prostatitis with Secondary Premature Ejaculation.
Objective To evaluate the effect of interventions for premature ejaculation (PE) in the management of patients with chronic prostatitis and secondary premature ejaculation. Methods Totally 90 patients diagnosed as chronic prostatitis with PE were randomly divided into control group (n=45) and interventional group (n=45). Control group received a conventional therapy consisted of oral administration of antibiotics,α-receptor blocker,and proprietary Chinese medicine for clearing away heat and promoting diuresis. Interventional group received a conventional therapy combined with treatment for ameliorating the PE symptom (oral dapoxetine on-demand and ejaculation control exercise).National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI),Chinese Index of Sexual Function for Premature Ejaculation (CIPE)-5 questionnaires,intravaginal ejaculatory latency time,and the number of coituses per week were applied for evaluating the treatment outcomes. Results Follow-up was accomplished in 35 and 38 patients in the control and interventional group.The CIPE-5 score,intravaginal ejaculatory latency time,and the number of coituses per week were significantly improved in both two groups but more significantly in interventional group (all P<0.05). The NIH-CPSI pain,urination,and quality of life subscores and total score were improved significantly in both two groups after treatment,but the NIH-CPSI pain and quality of life subscores had been improved more significantly in the interventional group (all P<0.05). The variation of NIH-CPSI was negatively correlated with that of CIPE-5 in both two groups (r=-0.362,P=0.016;r=-0.330,P=0.021). Conclusions For CP with secondary PE patients,the interventions for PE can not only improve the quality of sexual life but also help improve the NIH-CPSI pain and quality of life subscores. PE should be routinely screened and treated during the management of CP.p.
Department of Urology,Shanghai Pudong Hospital,Fudan University Pudong Medical Center,Shanghai 201399,China.
Chang-Qing
CQ
Chen
Department of Urology,Shanghai Pudong Hospital,Fudan University Pudong Medical Center,Shanghai 201399,China.
Qing-Tong
QT
Yi
Department of Urology,Shanghai Pudong Hospital,Fudan University Pudong Medical Center,Shanghai 201399,China.
Chu-Hong
CH
Chen
Department of Urology,Shanghai Pudong Hospital,Fudan University Pudong Medical Center,Shanghai 201399,China.
Min
M
Gong
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002908:Chronic Disease; D059350:Chronic Pain; D003075:Coitus; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D004542:Ejaculation; D006801:Humans; D008297:Male; D061686:Premature Ejaculation / Q000188:drug therapy* / Q000209:etiology*; D011472:Prostatitis / Q000150:complications* / Q000188:drug therapy*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D004365:Drugs, Chinese Herbal